Sugentech Inc. (KOSDAQ:253840)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,910.00
-210.00 (-3.43%)
Feb 19, 2026, 1:50 PM KST
Market Cap93.57B -20.7%
Revenue (ttm)9.01B -7.2%
Net Income-20.81B
EPS-1,363.97
Shares Out15.29M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume404,205
Average Volume447,451
Open6,070.00
Previous Close6,120.00
Day's Range5,800.00 - 6,150.00
52-Week Range4,910.00 - 9,390.00
Beta0.54
RSI46.33
Earnings DateFeb 27, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 144
Stock Exchange KOSDAQ
Ticker Symbol 253840
Full Company Profile

Financial Performance

In 2024, Sugentech's revenue was 10.10 billion, an increase of 41.57% compared to the previous year's 7.13 billion. Losses were -15.19 billion, -11.87% less than in 2023.

Financial Statements